- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06314178
Assessing Demographic Biases in Deep Learning Model for Fetal Growth Estimation in Clinical Practice. Patients Eligible for Inclusion Are Women With a Gestational Age Between 24-42 Weeks Undergoing a Third-trimester Growth Scan. The Image Data From the Scan Are Used to Calculate Fetal Weight.
March 13, 2024 updated by: Julie Leth-Petersen, Copenhagen Academy for Medical Education and Simulation
Assessing Demographic Biases in Deep Learning Model for Fetal Growth Estimation in Clinical Practice
The goal of this observational study is to compare a new artificial intelligence (AI) feedback tool with the traditional method for estimating fetal weight during ultrasound scans on pregnant women between 24-42 weeks of gestation.
The study aims to investigate the presence of demographic bias in the AI model.
The demographic factors examined in the study include Body Mass Index (BMI), the number of births, fetal age, mother's age, fetal sex, and the presence of preeclampsia.
Moreover, the study will compare the accuracy of the AI model and the Hadlock model, a fetal growth formula, in estimating fetal weight.
Participants will have their ultrasound scans pseudonymized and securely stored on password-protected removable drives, ensuring their identity and privacy are maintained.
Afterward, the ultrasound data will be sent to the Technical University of Denmark (DTU), where the AI model will analyze the images to estimate fetal weight.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Julie Leth-Petersen
- Phone Number: +4526399590
- Email: julie.leth-petersen@regionh.dk
Study Contact Backup
- Name: Martin Grønnebæk Tolsgaard
- Phone Number: 38 66 46 31
- Email: martin.groennebaek.tolsgaard@regionh.dk
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Department of Prenatal Examinations at Rigshospitalet, Copenhagen, Denmark.
Description
Inclusion Criteria:
- Women with gestational age between 24-42 weeks undergoing a third-trimester growth scan.
Exclusion Criteria:
- Women with multiple pregnancies.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Pregnant women between 24-42 weeks of gestation
No interventions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Demographic biases
Time Frame: From enrollment to the birth of the child
|
The primary objective is to investigate potential demographic biases inherent in the deep learning model developed for estimating fetal growth in clinical practice.
This is achieved by comparing the relative error between fetal weight at scan time (this value is extrapolated from the birth weight using the Marsal growth curve) and estimations from the Hadlock formula and the deep learning model.
|
From enrollment to the birth of the child
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comparing the accuracy of the Hadlock formula and the AI model
Time Frame: From enrollment to the birth of the child
|
The secondary objective is to compare the accuracy of fetal weight estimation between the Hadlock formula and a deep learning model in clinical practice using a paired t-test.
|
From enrollment to the birth of the child
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 15, 2024
Primary Completion (Estimated)
July 30, 2024
Study Completion (Estimated)
July 30, 2024
Study Registration Dates
First Submitted
March 6, 2024
First Submitted That Met QC Criteria
March 13, 2024
First Posted (Actual)
March 15, 2024
Study Record Updates
Last Update Posted (Actual)
March 15, 2024
Last Update Submitted That Met QC Criteria
March 13, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- p-2024-15469
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Complications
-
The Cooper Health SystemRecruitingPregnancy,Neoplastic ComplicationsUnited States
-
Northwestern UniversityTerminatedPregnancy Related | Labor ComplicationUnited States
-
The George Washington University Biostatistics...Eunice Kennedy Shriver National Institute of Child Health and Human Development...Terminated
-
Jazz PharmaceuticalsRecruitingPregnancy | Pregnancy Complication | Maternal Complications | Birth Outcomes, AdverseUnited States
-
Oslo University HospitalRecruitingPregnancy Related | Labor Complication | Induced; BirthNorway
-
Thomas Jefferson UniversityCompleted
-
Washington University School of MedicineUniversity of MichiganRecruiting
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompleted
-
University Hospital Center of MartiniqueCompletedLabor Complication | CervixMartinique
-
PerspectumUniversity of Oxford; Fetal Medicine FoundationCompletedPregnancy Complications | Fetal Growth ComplicationsUnited Kingdom